These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29409840)

  • 21. A comparison of background membrane imaging versus flow technologies for subvisible particle analysis of biologics.
    Vargas SK; Eskafi A; Carter E; Ciaccio N
    Int J Pharm; 2020 Mar; 578():119072. PubMed ID: 32001293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
    Gikanga B; Hui A; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of Three Flow Imaging Microscopy Instruments for Image Analysis in Evaluating four Types of Subvisible Particle in Biopharmaceuticals.
    Nishiumi H; Deiringer N; Krause N; Yoneda S; Torisu T; Menzen T; Friess W; Uchiyama S
    J Pharm Sci; 2022 Nov; 111(11):3017-3028. PubMed ID: 35948157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Evaluation of Two Methods for Preparative Fractionation of Proteinaceous Subvisible Particles--Differential Centrifugation and FACS.
    Boll B; Folzer E; Finkler C; Huwyler J; Mahler HC; Schmidt R; Koulov AV
    Pharm Res; 2015 Dec; 32(12):3952-64. PubMed ID: 26195006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shape Characterization of Subvisible Particles Using Dynamic Imaging Analysis.
    Mathaes R; Manning MC; Winter G; Engert J; Wilson GA
    J Pharm Sci; 2020 Jan; 109(1):375-379. PubMed ID: 31476311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of subvisible silicone oil droplets from irregular standard dust particles.
    Vandesteeg N; Kilbert C
    J Pharm Sci; 2013 Jun; 102(6):1696-1700. PubMed ID: 23595940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Platform for Preparing Homogeneous Proteinaceous Subvisible Particles With Distinct Morphologies.
    Schack MM; Møller EH; Carpenter JF; Rades T; Groenning M
    J Pharm Sci; 2018 Jul; 107(7):1842-1851. PubMed ID: 29574228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Machine Learning Analysis Provides Insight into Mechanisms of Protein Particle Formation Inside Containers During Mechanical Agitation.
    Thite NG; Ghazvini S; Wallace N; Feldman N; Calderon CP; Randolph TW
    J Pharm Sci; 2022 Oct; 111(10):2730-2744. PubMed ID: 35835184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Watch out for a revival of peginesatide in sports.
    Jelkmann W
    Drug Test Anal; 2017 Feb; 9(2):157-160. PubMed ID: 27279382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid Quantification of Protein Particles in High-Concentration Antibody Formulations.
    Wu H; Randolph TW
    J Pharm Sci; 2019 Mar; 108(3):1110-1116. PubMed ID: 30773198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Protein Particles in Therapeutic Formulations Using Imaging Flow Cytometry.
    Probst C; Zeng Y; Zhu RR
    J Pharm Sci; 2017 Aug; 106(8):1952-1960. PubMed ID: 28456724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Machine learning and statistical analyses for extracting and characterizing "fingerprints" of antibody aggregation at container interfaces from flow microscopy images.
    Daniels AL; Calderon CP; Randolph TW
    Biotechnol Bioeng; 2020 Nov; 117(11):3322-3335. PubMed ID: 32667683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applying Pattern Recognition as a Robust Approach for Silicone Oil Droplet Identification in Flow-Microscopy Images of Protein Formulations.
    Chen XG; Graužinytė M; van der Vaart AW; Boll B
    J Pharm Sci; 2021 Apr; 110(4):1643-1651. PubMed ID: 33122049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow imaging: moving toward best practices for subvisible particle quantitation in protein products.
    Wilson GA; Manning MC
    J Pharm Sci; 2013 Mar; 102(3):1133-4. PubMed ID: 23303598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unmasking translucent protein particles by improved micro-flow imaging™ algorithms.
    Pedersen JS; Persson M
    J Pharm Sci; 2014 Jan; 103(1):107-14. PubMed ID: 24281987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Separation, Characterization and Discriminant Analysis of Subvisible Particles in Biologics Formulations.
    Akhunzada ZS; Hubert M; Sahin E; Pratt J
    Curr Pharm Biotechnol; 2019; 20(3):232-244. PubMed ID: 30767738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensive Chemical Modifications in the Primary Protein Structure of IgG1 Subvisible Particles Are Necessary for Breaking Immune Tolerance.
    Boll B; Bessa J; Folzer E; Ríos Quiroz A; Schmidt R; Bulau P; Finkler C; Mahler HC; Huwyler J; Iglesias A; Koulov AV
    Mol Pharm; 2017 Apr; 14(4):1292-1299. PubMed ID: 28206769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convolutional Neural Networks Enable Highly Accurate and Automated Subvisible Particulate Classification of Biopharmaceuticals.
    Wang S; Liaw A; Chen YM; Su Y; Skomski D
    Pharm Res; 2023 Jun; 40(6):1447-1457. PubMed ID: 36471026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging Flow Cytometry for Sizing and Counting of Subvisible Particles in Biotherapeutics.
    Helbig C; Menzen T; Wuchner K; Hawe A
    J Pharm Sci; 2022 Sep; 111(9):2458-2470. PubMed ID: 35777484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subvisible Particulate Contamination in Cell Therapy Products-Can We Distinguish?
    Vollrath I; Mathaes R; Sediq AS; Jere D; Jörg S; Huwyler J; Mahler HC
    J Pharm Sci; 2020 Jan; 109(1):216-219. PubMed ID: 31521641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.